New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...

Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

A new study published in the Journal of American Medical Association showed no advantage to immediate coronary angiography ...

These survival data are unprecedented in ALS clinical trial history. Five-Year Survival ... But in heterogeneous rare diseases with small populations and short placebo-controlled trials, efficacy ...

USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Some forgetfulness is part of the aging process. Recognizing when it could be something more can help families cope with a ...

Researchers are studying whether Ginkgo biloba leaves might support weary leg veins and cut the risk of blood clots.

Thermo Fisher's core pharma, biotech, and bioproduction businesses are driving growth. Click here to read why TMO stock is a ...

The bots, when tested alone, performed impressively - correctly identifying medical conditions 95% of the time. But when real ...

Londoners may be interested to know that a variety of historical links to the Ottoman Empire are closer to home than they ...

The signers acknowledged that leaders of their professions had previously condemned a street protest against lockdown ...